Bio-Key Intl Inc (BKYI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.7944 +0.0454 (+6.06%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.7300 -0.0644 (-8.11%) 19:57 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -4,301 | -8,522 | -11,910 | -5,066 | -9,674 |
Depreciation Amortization | 777 | 601 | 497 | 410 | 4,592 |
Income taxes - deferred | -23 | -134 | -20 | N/A | N/A |
Accounts receivable | 856 | -429 | -339 | -673 | -237 |
Accounts payable and accrued liabilities | -503 | 58 | 239 | 184 | -600 |
Other Working Capital | 788 | -194 | -299 | -5,280 | -1,430 |
Other Operating Activity | -508 | 4,827 | 5,603 | 1,447 | 2,400 |
Operating Cash Flow | $-2,914 | $-3,794 | $-6,229 | $-8,978 | $-4,950 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | N/A | N/A | N/A | -513 |
PPE Investments | -13 | -1 | -82 | -42 | -36 |
Net Acquisitions | N/A | N/A | -624 | N/A | -1,899 |
Sale Of Investment | N/A | N/A | N/A | N/A | 513 |
Other Investing Activity | 0 | 0 | 9 | 0 | -295 |
Investing Cash Flow | $-13 | $-1 | $-697 | $-42 | $-2,230 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 2,000 | N/A | 2,002 | N/A | 3,958 |
Debt Repayment | -150 | -119 | N/A | N/A | N/A |
Common Stock Issued | 1,912 | 4,314 | 56 | 37 | 25,084 |
Other Financing Activity | -935 | -2,761 | -155 | -255 | -4,948 |
Financing Cash Flow | $2,827 | $1,433 | $1,903 | $-219 | $24,094 |
Exchange Rate Effect | 27 | 237 | -96 | N/A | N/A |
Beginning Cash Position | 511 | 2,636 | 7,754 | 16,993 | 79 |
End Cash Position | 438 | 511 | 2,636 | 7,754 | 16,993 |
Net Cash Flow | $-74 | $-2,124 | $-5,119 | $-9,239 | $16,914 |
Free Cash Flow | |||||
Operating Cash Flow | -2,914 | -3,794 | -6,229 | -8,978 | -4,950 |
Capital Expenditure | -13 | -1 | -82 | -42 | -36 |
Free Cash Flow | -2,927 | -3,795 | -6,311 | -9,020 | -4,986 |